Incidence & Outcomes of Emergency Department Patients Requiring Emergency

See also
Status	Clinical Trial	Phase
Terminated	`NCT06118359` - Development and Pilot Testing the SITe Intervention	N/A
Completed	`NCT04216394` - Anticoagulation in Emergency General Surgery
Completed	`NCT04419571` - Outcomes in Emergency Laparotomies During COVID-19 Pandemic
Not yet recruiting	`NCT06043414` - Barbed Suture vs Non-Barbed Closure for Emergency Exploratory Laparotomy RCT	N/A

See also

Status

Clinical Trial

Phase

Terminated

NCT06118359 - Development and Pilot Testing the SITe Intervention

N/A

Completed

NCT04216394 - Anticoagulation in Emergency General Surgery

Completed

NCT04419571 - Outcomes in Emergency Laparotomies During COVID-19 Pandemic

Not yet recruiting

NCT06043414 - Barbed Suture vs Non-Barbed Closure for Emergency Exploratory Laparotomy RCT

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05664360
Study type	Observational
Source	University Hospital, Geneva
Contact
Status	Completed
Phase
Start date	January 1, 2015
Completion date	March 15, 2022

Incidence and Outcomes of Emergency Department Patients Requiring Emergency General Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms